https://doi.org/10.4081/reumatismo.2014.784

Emerging therapies for osteoporosis

Vol. 66 No. 2 (2014)
Submitted: 28 July 2014
Accepted: 28 July 2014
Published: 28 July 2014
Osteoporosis, Emerging therapies.
Abstract Views: 1686
PDF: 1285
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

G. Minisola
gminisola@scamilloforlanini.rm.it
Azienda Ospedaliera “San Camillo-Forlanini”, Ospedale di Alta Specializzazione “San Camillo”, Divisione di Reumatologia, Roma, Italy.
A. Iuliano
Azienda Ospedaliera “San Camillo-Forlanini”, Ospedale di Alta Specializzazione “San Camillo”, Divisione di Reumatologia, Roma, Italy.
I. Prevete
Azienda Ospedaliera “San Camillo-Forlanini”, Ospedale di Alta Specializzazione “San Camillo”, Divisione di Reumatologia, Roma, Italy.
Currently available drugs for the treatment of osteoporosis can still be improved in terms of pharmacokinetics, pharmacodynamics and management. New approaches for the development of innovative drugs are possible thanks to our increasing understanding of the bone tissue biology and the cellular and molecular processes that regulate it. One of the new anti-bone resorption agents, odanacatib, a selective cathepsin-K inhibitor, is in late phase III clinical research. Among new bone anabolic drugs, those that have an action on the Wnt signaling pathway appear to be particularly promising. The development of new compounds for the treatment of osteoporosis represents an excellent example of translational medicine efforts aimed to extend the range of treatment options for osteoporosis, a very common disease with a high social and economic impact, particularly when causing fractures.

Dimensions

Altmetric

PlumX Metrics

Downloads

Download data is not yet available.

Citations

Crossref
Scopus
Google Scholar
Europe PMC

How to Cite

Minisola, G., Iuliano, A., & Prevete, I. (2014). Emerging therapies for osteoporosis. Reumatismo, 66(2), 112–124. https://doi.org/10.4081/reumatismo.2014.784

Authors who publish with this journal agree to the following terms:

  1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
  2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
  3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.